We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK has approved Moderna’s COVID-19 vaccine through a temporary authorization pathway, gaining a third option to add to approved vaccines from AstraZeneca/Oxford University and Pfizer/BioNTech. Read More
The late-stage trial found that the safety and tolerability of the drug was consistent with its well-established safety profile, AstraZeneca said. Read More
The European Commission granted conditional marketing authorization for Moderna’s highly effective COVID-19 vaccine Wednesday, adding a second messenger RNA-based vaccine to its arsenal against the pandemic. Read More
The once-a-week therapy “could help reduce the burden of daily growth hormone injections on children, their loved ones and caregivers,” said Brenda Cooperstone, Pfizer’s chief development officer for rare diseases. Read More
The agency said that Amphastar’s generic drug is a synthetic version of human glucagon, a hormone that prompts the liver to quickly increase blood sugar levels. Read More